Low‐molecular‐weight fucoidan and high‐stability fucoxanthin decrease serum alanine transaminase in patients with nonalcoholic fatty liver disease—A double‐blind, randomized controlled trial

2019 ◽  
Vol 6 (3) ◽  
pp. 116-122 ◽  
Author(s):  
I‐Ching Cheng ◽  
Shih‐Yen Weng ◽  
Ming‐Shun Wu ◽  
Fat‐Moon Suk ◽  
Gi‐Shih Lien ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document